CIK 0001761918 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Erasca, Inc.
Sign in to watch- Ticker
- ERAS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831217027
- Phone
- (858) 465-6511
- Business address
- 3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-01 | LIU JEAN I Director | Grant or award · Stock Option (right to buy) | +20,617 | 20,617 | ||
| 2026-01-01 | Multani Pratik S Director | Grant or award · Stock Option (right to buy) | +19,532 | 19,532 | ||
| 2026-01-01 | Start Valerie Denise Harding Director | Grant or award · Stock Option (right to buy) | +24,306 | 24,306 | ||
| 2026-01-01 | Casdin Alexander W. Director | Grant or award · Stock Option (right to buy) | +23,872 | 23,872 | ||
| 2025-12-15 | Chacko David M. CFO and CBO | Other acquisition | +17,793 | $1.19 | $21K | 279,980 |
| 2025-12-15 | Garner Ebun General Counsel & Corp. Sec. | Grant or award 10b5-1 | +3,902 | $1.19 | $5K | 25,076 |
| 2025-06-24 | Varney Michael David Director | Grant or award · Stock option (right to buy) | +120,000 | 120,000 | ||
| 2025-06-24 | LIU JEAN I Director | Grant or award · Stock option (right to buy) | +120,000 | 120,000 | ||
| 2025-06-24 | Hambleton Julie Director | Grant or award · Stock option (right to buy) | +120,000 | 120,000 | ||
| 2025-06-24 | Start Valerie Denise Harding Director | Grant or award · Stock option (right to buy) | +120,000 | 120,000 | ||
| 2025-06-24 | Multani Pratik S Director | Grant or award · Stock option (right to buy) | +120,000 | 120,000 | ||
| 2025-06-24 | Bristol James Arthur Director | Grant or award · Stock option (right to buy) | +120,000 | 120,000 | ||
| 2025-06-24 | Casdin Alexander W. Director | Grant or award · Stock option (right to buy) | +120,000 | 120,000 | ||
| 2025-05-23 | Multani Pratik S Director | Gift | −6,200 | 166,666 | ||
| 2025-05-23 | Multani Pratik S Director | Gift | +6,200 | 6,200 | ||
| 2025-03-04 | Morris Shannon Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 515,800 | ||
| 2025-02-13 | Garner Ebun General Counsel & Corp. Sec. | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2025-02-03 | Chacko David M. CFO and CBO | Grant or award · Stock option (right to buy) | +800,000 | 800,000 | ||
| 2025-02-03 | Morris Shannon Chief Medical Officer | Grant or award · Stock option (right to buy) | +780,000 | 780,000 | ||
| 2025-02-03 | Garner Ebun General Counsel & Corp. Sec. | Grant or award · Stock option (right to buy) | +700,000 | 700,000 |
Page 2 of 7 · 121 trades